Skip to main content
Patient Data Protected
LegitScript Verified
256-bit Encrypted
Licensed Physicians
Direct Payment
Medically reviewed byDr. Rachel Morrison, MD, ABOM·Updated July 2026
Your Medication

It's not about willpower - it's about biology

GLP-1 medications are FDA-approved, clinically proven, and work with your body's own hunger signals. No stimulants. No crash diets.

Board-certified physiciansPatient data protected15,000+ patients treated
Medically reviewed by Dr. Rachel Morrison, MD, ABOM · Updated July 2026
22.5%
avg. total body weight loss
94%
lean muscle retained
1x/week
simple injection
12,400+
clinical trial participants
Mechanism of Action

How GLP-1/GIP dual agonists work

Unlike older weight loss medications, GLP-1 agonists work with your body's natural hormone pathways - not against them.

Reduces appetite at the source

Activates GLP-1 receptors in the hypothalamus - your brain's appetite control center. Patients describe the constant mental chatter about food ("food noise") going quiet within days of starting treatment.

Slows gastric emptying

Delays how quickly food leaves your stomach, extending fullness after smaller meals. Dual-receptor activation amplifies this effect with significantly less nausea than older single-receptor GLP-1 medications.

Regulates blood sugar

Mimics the naturally-occurring GLP-1 hormone to improve insulin sensitivity and stabilize blood glucose. Reduces cravings for sugar and processed carbohydrates by preventing blood sugar spikes and crashes.

Preserves lean muscle mass

GIP receptor activation preferentially targets fat stores while protecting lean tissue. Patients retain 94% of lean mass - compared to older GLP-1s where up to 30% of weight lost was muscle, not fat.

Wondering if this medication is right for you? Free physician review takes 5 minutes.

Check my eligibility →
Dual-Receptor Advantage

Why GLP-1/GIP is the next generation

Single-receptor GLP-1 medications (like semaglutide) target only one pathway. Our dual-agonists activate both GLP-1 and GIP receptors for superior results.

  • 22.5% weight loss vs. 16.9% for semaglutide alone
  • Up to 28.6% with our advanced triple-agonist protocol for patients who need more
  • 94% lean muscle retention vs. ~70% for older GLP-1s
  • Lower nausea rates due to GIP buffering effect
  • Improved cardiovascular markers
  • Once-weekly dosing - same convenience

Clinical trial results

NEJM, 2023: N=2,539. Dual GLP-1/GIP agonist achieved 22.5% total body weight loss over 72 weeks vs. 3.1% placebo.

The Lancet, 2023: N=1,800+. Body composition analysis showed 94% lean mass retention, significantly outperforming single-receptor protocols.

Individual results vary. Treatment prescribed only if clinically appropriate.

Safety

Side effects and safety information

Most side effects are mild, temporary, and resolve within the first few weeks of treatment.

Common side effects

Nausea - Most common in first 1-2 weeks, typically resolves. Manageable with dose titration.

Decreased appetite - Expected therapeutic effect.

Mild GI symptoms - Constipation or diarrhea in some patients, usually temporary.

Injection site reaction - Mild redness that resolves quickly.

Who should not take GLP-1s

Contraindicated for patients with:

• Personal/family history of medullary thyroid carcinoma or MEN 2 syndrome
• History of pancreatitis
• Pregnancy or breastfeeding
• Severe gastroparesis
• Type 1 diabetes

Your physician screens for all contraindications during review.

Your Schedule

What your dosing timeline looks like

We start low and increase gradually. This minimizes side effects and lets your body adjust at a comfortable pace.

Weeks 1–42.5 mg/week

Starting dose

Your body adjusts to the medication. Most patients notice reduced appetite and less food noise within the first 2 weeks. Mild nausea is possible but typically resolves quickly.

Weeks 5–85 mg/week

First increase

Weight loss accelerates. Patients typically lose 3–5% of body weight by this stage. Your physician reviews your progress and adjusts if needed.

Weeks 9–127.5 mg/week

Therapeutic range

Significant weight loss visible. Most side effects have resolved. Energy levels improve and patients report better sleep and mood.

Weeks 13–1610 mg/week

Full dose

Peak weight loss period. Patients are typically losing 1–2 lbs per week steadily. Lab markers (A1C, cholesterol, blood pressure) improving.

Week 17+10–15 mg/week

Maintenance

Dose optimized for your response. Some patients maintain at 10mg, others benefit from 15mg. Your physician works with you on a long-term plan to sustain results.

Titration schedule shown is for tirzepatide. Your physician may adjust based on tolerance and response. Not all patients require every dose step.

Medication questions

How do GLP-1 medications work?
GLP-1 agonists mimic a hormone your body naturally produces (glucagon-like peptide-1) to regulate appetite and blood sugar. They reduce hunger signals in your brain, slow gastric emptying so you feel full longer, and improve insulin sensitivity. They are stimulant-free and non-habit forming.
How is this different from Ozempic or Wegovy?
Ozempic and Wegovy contain semaglutide - a single-receptor GLP-1 agonist. Our standard treatment uses a dual GLP-1/GIP receptor agonist, which activates both pathways simultaneously for greater weight loss (22.5% vs. 16.9% for semaglutide), better muscle retention, and lower nausea rates. For patients who need more, our advanced triple-agonist protocol achieves up to 28.6%.
Will I gain the weight back if I stop?
Clinical data shows some weight regain after discontinuation, which is why we work with you on a maintenance protocol. Many patients transition to a lower maintenance dose rather than stopping completely. Your physician develops a long-term plan tailored to your goals.
Will GLP-1s interact with my current medications?
GLP-1 medications can interact with certain drugs, particularly diabetes medications, blood thinners, and oral contraceptives (due to slowed absorption). Your physician reviews all your current medications during screening and monitors for interactions.
Is it safe long-term?
GLP-1 medications have been studied for over 15 years with a strong safety profile. Long-term trials show sustained efficacy with continued use. Your physician monitors you throughout treatment and adjusts as needed.
Medication Comparisons

How we compare to brand-name medications

See detailed side-by-side comparisons of Linux Health vs. popular GLP-1 brands - weight loss, cost, side effects, and more.

Physician review in 24–48 hours

Curious if GLP-1 treatment could work for you?

Take the free screening - a physician reviews your answers within 48 hours.

15,000+
Patients treated
22.5%
Avg weight loss
4.9/5
Patient rating
Take the free screening →
No credit card required Cancel anytime Only pay if approved

Get weight loss insights, delivered weekly

Evidence-based tips from our clinical team. No spam, unsubscribe anytime.

Join 4,200+ subscribers
15,000+ patients treated nationwide
Start Free Screening →
💋
Wait — your free screening takes just 5 minutes
15,000+ patients started here. No credit card needed.
Start my free screening
HIPAA compliant
Board-certified MDs